Advanced search
Publication Cover
Leukemia & Lymphoma Volume 65, 2024 - Issue 5
Submit an article Journal homepage
37
Views
0
CrossRef citations to date
0
Altmetric
Letters to the Editor

BIRC-3 mutated monoclonal B lymphocytosis without evolution to chronic lymphocytic leukemia (CLL)

Amen Allah Nasra APHP-Paris Saclay, Service d’Hématologie-Bicêtre, Kremlin-Bicêtre, France;b Faculté de Médecine Paris-Saclay, Université Paris-Saclay, Kremlin-Bicêtre, France;c Inserm UMR-S 1310, Villejuif, FranceView further author information
,
Xavier Fundc Inserm UMR-S 1310, Villejuif, France;d APHP Paris Saclay Service d’Oncohématologie moléculaire et Cytogénétique Hôpital Paul-Brousse, Villejuif, FranceView further author information
,
Sylvain Barreaua APHP-Paris Saclay, Service d’Hématologie-Bicêtre, Kremlin-Bicêtre, France;c Inserm UMR-S 1310, Villejuif, FranceView further author information
,
Christophe Desterkeb Faculté de Médecine Paris-Saclay, Université Paris-Saclay, Kremlin-Bicêtre, France;c Inserm UMR-S 1310, Villejuif, FranceView further author information
,
Claire Boriec Inserm UMR-S 1310, Villejuif, France;d APHP Paris Saclay Service d’Oncohématologie moléculaire et Cytogénétique Hôpital Paul-Brousse, Villejuif, FranceView further author information
,
Noufissa Oudrhiria APHP-Paris Saclay, Service d’Hématologie-Bicêtre, Kremlin-Bicêtre, France;c Inserm UMR-S 1310, Villejuif, France;d APHP Paris Saclay Service d’Oncohématologie moléculaire et Cytogénétique Hôpital Paul-Brousse, Villejuif, FranceView further author information
,
Jamila Faivred APHP Paris Saclay Service d’Oncohématologie moléculaire et Cytogénétique Hôpital Paul-Brousse, Villejuif, FranceView further author information
,
A. Bennaceur-Griscellia APHP-Paris Saclay, Service d’Hématologie-Bicêtre, Kremlin-Bicêtre, France;b Faculté de Médecine Paris-Saclay, Université Paris-Saclay, Kremlin-Bicêtre, France;c Inserm UMR-S 1310, Villejuif, France;d APHP Paris Saclay Service d’Oncohématologie moléculaire et Cytogénétique Hôpital Paul-Brousse, Villejuif, France;e Centre for iPSC Therapies (CITHERA) INSERM UMS 45, GenopoleEvry, FranceView further author information
&
A. G. Turhana APHP-Paris Saclay, Service d’Hématologie-Bicêtre, Kremlin-Bicêtre, France;b Faculté de Médecine Paris-Saclay, Université Paris-Saclay, Kremlin-Bicêtre, France;c Inserm UMR-S 1310, Villejuif, France;d APHP Paris Saclay Service d’Oncohématologie moléculaire et Cytogénétique Hôpital Paul-Brousse, Villejuif, France;e Centre for iPSC Therapies (CITHERA) INSERM UMS 45, GenopoleEvry, France;f Department of Hematology, American Hospital of Paris, Neuilly Sur Seine, FranceCorrespondence[email protected]
View further author information
 show all
Pages 692-695 | Received 20 Nov 2023, Accepted 17 Jan 2024, Published online: 31 Jan 2024

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.